The latest systematic review on olanzapine for schizophrenia treatment has defined a therapeutic reference range of 20-40 ng/mL, offering insight into optimal efficacy and tolerable levels. Explore the full study to understand how these findings can inform clinical practice and patient care.

In a recent phase 2 trial involving patients with narcolepsy type 1, oral orexin receptor 2-selective agonist TAK-994 exhibited promising results in improving sleep latency and reducing cataplexy. However, the study was terminated early due to hepatotoxic effects, underscoring the need for further evaluation and refinement of the treatment approach.

Dr. Charlie Teo’s recent guilty verdict for unsatisfactory professional conduct brings forth a significant conversation on the balance between risk-taking and ethics within surgical practices. The case highlights the critical role of proper judgment, informed consent, and professional communication in patient care, a topic worthy of examination and reflection by all medical practitioners.

The recent incident involving a TikTok doctor losing her medical license highlights the nuanced challenges physicians face when engaging with social media. Consider the implications on patient privacy, consent, and professionalism, and approach online content with caution and integrity.

With 2023 witnessing significant jury awards and legal reforms, the landscape of medical malpractice is undeniably shifting. Discover the key trends, notable cases, and potential future challenges in a comprehensive overview that emphasizes the evolving dynamics within this critical aspect of healthcare practice.

The preliminary findings suggest a potential new direction for managing chronic pain in PTSD, inviting further research and consideration in the clinical field.